100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting Q5 CSI smv $3.80   Add to cart

Summary

Samenvatting Q5 CSI smv

 95 views  2 purchases
  • Course
  • Institution

Samenvatting CSI Q5 met ethiek, morele dilemma's, prenatale screening en diagnostie, dure medicijnen en targeted therapy, en diagnostiek en screening bij kanker

Preview 3 out of 27  pages

  • June 21, 2019
  • 27
  • 2018/2019
  • Summary
avatar-seller
CSI Q5
Samenvatting




Lieke Schönberger

,Inhoud
Morele dilemma’s ................................................................................................................................... 5
Ethische problemen............................................................................................................................. 5
Moraal en moraliteit ........................................................................................................................... 5
Ethische uitspraken ............................................................................................................................. 6
Methodische aanpak ........................................................................................................................... 6
Gebruik van morele termen ................................................................................................................ 7
Recht en ethiek.................................................................................................................................... 8
Morele theorieën ................................................................................................................................ 9
Meta-ethiek ......................................................................................................................................... 9
Redeneren, argumenteren en ethische principes ............................................................................... 9
Wat is een argument? ................................................................................................................... 10
Ethisch argumenteren ................................................................................................................... 10
Autonomie ......................................................................................................................................... 10
Paternalisme .................................................................................................................................. 10
Verantwoord medisch handelen ....................................................................................................... 11
Prenatale screening en diagnostiek ...................................................................................................... 13
Prenatale screening ........................................................................................................................... 13
Screening op T21, T18 en T13 ........................................................................................................... 14
Testkarakteristieken .......................................................................................................................... 15
Combinatietest .................................................................................................................................. 15
NIPT ................................................................................................................................................... 16
Invasief prenatale testen ................................................................................................................... 16
SEO (20 weken echo) ......................................................................................................................... 17
GUO (Geavanceerd Ultrageluid Onderzoek) ..................................................................................... 18
Zwangerschapsbeëindiging ............................................................................................................... 18
Dure medicijnen en targeted therapy ................................................................................................... 20
Ipilimumab..................................................................................................................................... 20
Nederlandse Vereniging voor Medische Oncologie (NVMO) ........................................................ 20
Patent ............................................................................................................................................ 20
Monoclonale antilichamen ............................................................................................................ 21
Kostenbeperking............................................................................................................................ 21
Medicijnsluis .................................................................................................................................. 21
Genetica borstkanker en eierstokkanker .......................................................................................... 22
Moleculaire doelgerichte behandelingen ......................................................................................... 22
Hiërarchie in de doelwitten ........................................................................................................... 23

, Tumorboard....................................................................................................................................... 24
Drug development............................................................................................................................. 24
Kanker; diagnose en screening .............................................................................................................. 26
Principes van vroege diagnostiek ...................................................................................................... 26
Screening voor kanker ....................................................................................................................... 27

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller LiekeSchonberger. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $3.80. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

64438 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$3.80  2x  sold
  • (0)
  Add to cart